Abscopal effect in a patient with melanoma

New England Journal of Medicine

Volumn 366, Issue 21, 2012, Pages 2035-2036

  Hiniker, Susan M ^a   Chen, Daniel S ^a   Knox, Susan J ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; IPILIMUMAB;

ABSCOPAL EFFECT; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL DEATH; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; DRUG EFFECT; DRUG EFFICACY; HUMAN; IMMUNOREACTIVITY; LETTER; LIVER METASTASIS; MELANOMA; METASTASIS; MULTIPLE CYCLE TREATMENT; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION RESPONSE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84861398744     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1203984     Document Type: Letter

References (1)

1. Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012;366:925-31.